Quick Answer
Connect Biopharma Holdings Ltd reported Shares Outstanding of 56.44 million shares for fiscal year 2025.
Connect Biopharma Holdings Ltd Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 56.44M | +2.0% |
| 2024 | 55.35M | +0.4% |
| 2023 | 55.10M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 55.79M | — | +0.4% |
| June 30, 2025 | 55.58M | — | +0.4% |
| March 31, 2025 | 55.35M | — | +0.0% |
| December 31, 2024 | 55.35M | — | — |
- Connect Biopharma Holdings Ltd showed an increase of +2.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2023–2025 period, Connect Biopharma Holdings Ltd’s shares outstanding has grown by 2.4% (from 55.10 million shares to 56.44 million shares).
- The most recent figure is from Connect Biopharma Holdings Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: